Latest news and research on all cancers and treatments, updated several times a week, plus data base of these
“Age-standardised one-year relative survival is presented for breast, colorectal, lung,
ovarian and prostate cancers diagnosed in 2012. A comparison of all-stage survival in
2012 with a baseline of 2004-07 shows increasing survival across all cancer types with
an overall change of 8.3% in lung cancer, 6.5% in ovarian cancer, 6.3% in colorectal
cancer, 3.5% in prostate cancer and 1.6% in breast cancer”
“A PowerPoint presentation showing a comparison of cancer incidence and mortality worldwide and in the UK.” [Maybe of more interest to people in other countries is “Estimated Cancer Incidence, Mortality, and Prevalence Worldwide in 2012” from Globocan]
Kite Pharma, Inc., is a clinical-stage biopharmaceutical company engaged in the development of novel cancer immunotherapy products, with a ...
Kite Pharma Announces Presentations Highlighting Cancer Immunotherapy T Cell Manufacturing ... - Kite Pharma
The New York State Stem Cell Science Program (NYSTEM) recently awarded a 4-year $11.9 million grant to Roswell Park Cancer Institute (RPCI) in ...
“Genetically engineering our patients' immune-system T cells to efficiently attack and destroy cancer cells represents one of the most exciting ...
Cancer News in Science Daily
The amount of time a person sits during the day is associated with a higher risk of heart disease, diabetes, cancer, and death, regardless of regular exercise, according to a review study.
The global landscape of a portion of the genome that has not been previously well-explored has been the focus of recent study. This new analysis opens the door to discovery of thousands of potential new cancer biomarkers, the researchers say.
As main component of essential oils, terpenes can inhibit the growth of different cancer cells. Researchers have analyzed this process in liver cancer cells in detail. Their shed light upon the molecular mechanisms that resulted in cancer cells stop growing, following the application of (-)-citronellal, and they proved that the olfactory receptor OR1A2 is the crucial molecule for that purpose. In future, the olfactory receptor could serve as target for liver cancer diagnosis and therapy.
Tambahkan Komentar